Molecular and immunohistochemical analysis of ERBB2 expression in correlation with proliferation rate in synovial sarcoma

Diagn Mol Pathol. 2007 Dec;16(4):211-7. doi: 10.1097/PDM.0b013e3180621995.

Abstract

The aim of the study was to determine whether or not the tyrosine kinase receptor ERBB2 is overexpressed in synovial sarcomas (SSs). We also focused on the cell cycle-related nuclear protein-Ki-67. Thirty-two samples were available for immunohistochemistry and only 1 case revealed a weak diffuse membrane ERBB-2 staining. The remaining cases showed either no staining (20 cases) or weak focal membrane staining (9 cases). In our 3 highly overexpressed ERBB2 mRNA samples, fluorescence in situ hybridization showed no amplification of the ERBB2 gene. ERBB2 mRNA expression was present in all samples of SSs at a comparable level to that in breast carcinoma control group, with a 2+ or 3+ immunopositivity. The high level of ERBB2 mRNA expression correlated with a high level of Ki-67 mRNA. The level of Ki-67 mRNA correlated with Ki-67 protein expression. The study shows that ERBB2 mRNA expression is very strong in SSs, but the membrane ERBB-2 protein expression is practically absent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cell Proliferation
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence
  • Infant
  • Ki-67 Antigen / analysis
  • Ki-67 Antigen / genetics
  • Ki-67 Antigen / metabolism
  • Male
  • Middle Aged
  • RNA, Messenger / analysis*
  • RNA, Messenger / metabolism
  • Receptor, ErbB-2 / analysis*
  • Receptor, ErbB-2 / genetics
  • Receptor, ErbB-2 / metabolism
  • Sarcoma, Synovial / pathology*

Substances

  • Ki-67 Antigen
  • RNA, Messenger
  • ERBB2 protein, human
  • Receptor, ErbB-2